MAGI2 and focal segmental glomerulosclerosis: To investigate whether glomerular MAGI2 abundance can be used as a marker for progression of glomerular disease we performed a correlation analysis of MAGI2 and eGFR in kidney biopsies of patients suffering from FSGS, after kidney transplantation, and in diabetic kidney disease.